Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Ox40 Gene Expression and Its Serum Levels in New Cases of Patients With Multiple Sclerosis Publisher



Dabiri A1 ; Mansouri R2 ; Kazemi M3 ; Eskandari N4 ; Shaygannejad V5 ; Manian M6 ; Jahanbaniardakani H7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, International Campus, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  2. 2. Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  3. 3. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Applied Physiology Research Center, Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. Isfahan Medical Stud. Research Center (IMSRC), Isfahan University of Medical Scien., Isfahan, Iran

Source: Advances in Neuroimmune Biology Published:2018


Abstract

BACKGROUND: Multiple sclerosis (MS) is an autoimmune disease of human central nervous system (CNS). OX40 (CD134) is a member of the tumor necrosis factor (TNF) receptor family. Ligation of OX40 is crucial for clonal expansion of antigen-specific T-cells as well as survival and generation of T-cell memory. Soluble OX40 is the soluble form of OX40 and it has been demonstrated that it is correlated with some autoimmune disorders. OBJECTIVES: The purpose of this study was to investigate serum levels and gene expression of OX40 as a paraclinical marker in MS patients compared to the healthy control group. METHODS: In this research, 40 new cases of MS patients and 40 healthy people as control group were investigated. After extracting RNA from peripheral blood and cDNA synthesis, we examined gene expression using real-time PCR technique, and serum level of soluble OX40 was measured by commercially available ELISA kit. Additionally, Mann-Whitney test was used to compare the gene expression and serum levels between two groups. RESULTS: We did not find any significant correlation between OX40 gene expression and MS disease (p=0.715). Soluble OX40 serum levels of MS patients were not significantly different from the control group (P=0.409). CONCLUSIONS: According to the results of the current study, expression of OX40 gene as an inflammatory factor in peripheral blood and also serum levels of OX40 could not be considered paraclinical markers of this disease. © 2018 - IOS Press and the authors. All rights reserved.
Related Docs
View other Related Docs
1. Comparison of Ox40 Expression in Patients With Multiple Sclerosis and Neuromyelitis Optica As an Approach to Diagnosis, Allergy, Asthma and Clinical Immunology (2023)
2. Serum Ox40 Level in Patients With Neuromyelitis Optica, Journal of Isfahan Medical School (2016)
3. Expression of Ox40 Gene and Its Serum Levels in Neuromyelitis Optica Patients, Biomolecular Concepts (2019)
4. Toll Like Receptor 2 and 4 Expression in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients, Iranian Journal of Immunology (2014)
5. Ox40 Gene and Serum Protein Expression Profiles in Patients With Parkinson's Disease, Cell Journal (2018)
6. Evaluation of Matrix Metalloproteinase-9 Plasma Levels in Untreated New Relapsing–Remitting Multiple Sclerosis Patients and Their First-Degree Family, Metabolic Brain Disease (2021)
7. Serum Level of Interleukin 36 in Patients With Multiple Sclerosis, Journal of Immunoassay and Immunochemistry (2018)
8. Correlation of Ox40 Ligand on B Cells With Serum Total Ige and Il-4 Levels by Cd4 + T Cells in Allergic Rhinitis, Allergologia et Immunopathologia (2019)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (32)
Vahid Shaygannejad (26)
Other Related Docs
9. Investigation of Erg Gene Expression in Iranian Patients With Multiple Sclerosis, Immunological Investigations (2018)
10. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
11. Lncrnas Associated With Multiple Sclerosis Expressed in the Th1 Cell Lineage, Journal of Cellular Physiology (2019)
12. The Comparative Analysis of Serum Levels of Midkine in Patients With Multiple Sclerosis and Control Group, Journal of Isfahan Medical School (2013)
13. Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges, CNS and Neurological Disorders - Drug Targets (2018)
14. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
15. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
16. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
17. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)
18. Evaluation of the Expressed Mir‑129 and Mir‑549A in Patients With Multiple Sclerosis, Advanced Biomedical Research (2021)
19. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
20. The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica, Basic and Clinical Neuroscience (2021)
21. An Integrated Bioinformatics Analysis of the Potential Regulatory Effects of Mir-21 on T-Cell Related Target Genes in Multiple Sclerosis, Avicenna Journal of Medical Biotechnology (2021)
22. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
23. Higher Latitude Is Significantly Associated With an Earlier Age of Disease Onset in Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2016)
24. Cytokine Gene Expression in Newly Diagnosed Multiple Sclerosis Patients, Iranian Journal of Allergy, Asthma and Immunology (2015)
25. Cytomegalovirus Seroposivity in Iranian Multiple Sclerosis: A Randomized Case-Control Study, Pakistan Journal of Medical Sciences (2012)
26. Association Study Between Functional Polymorphisms of Mmp9 Gene Promoter and Multiple Sclerosis Susceptibility in an Iranian Population, Iranian Journal of Public Health (2019)
27. Neutralizing Antibodies in Multiple Sclerosis Patients on Weekly Intramuscular Avonex and Biosimilar Interferon Beta-1A (Cinnovex): Comparing Results of Measurements in Two Different Laboratories, Journal of Immunological Methods (2013)
28. Chlamydia Pneumoniae Seropositivity in Iranian Patients With Multiple Sclerosis: A Pilot Study; [Obecnosc Przeciwcial Przeciw Chlamydia Pneumoniae Wsrod Iranskich Chorych Na Stwardnienie Rozsiane: Badanie Pilotazowe], Neurologia i Neurochirurgia Polska (2011)
29. Association of Helicobacter Pylori With Multiple Sclerosis: Protective or Risk Factor?, Current Journal of Neurology (2020)
30. Increased Serum Level of Il-37 in Patients With Multiple Sclerosis and Neuromyelitis Optica, Acta Neurologica Belgica (2015)
31. The Effect of Plasma Exchange on the Expression of Foxp3 and Rorc2 in Relapsed Multiple Sclerosis Patients, Iranian Journal of Immunology (2015)
32. Atherosclerosis and Multiple Sclerosis: An Overview on the Prevalence of Risk Factors, Multiple Sclerosis and Related Disorders (2022)
33. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)
34. Upregulation of Mtor, Rps6kb1, and Eif4ebp1 in the Whole Blood Samples of Iranian Patients With Multiple Sclerosis Compared to Healthy Controls, Metabolic Brain Disease (2020)
35. Association of Aire Polymorphism and the Susceptibility to Multiple Sclerosis in Iranian Population, Avicenna Journal of Medical Biotechnology (2018)
36. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing–Remitting Multiple Sclerosis Patients, Inflammation (2022)
37. Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies, Future Neurology (2009)
38. Cerebrospinal Fluid and Serum Markers of Inflammation in Patients With Multiple Sclerosis, Advances in Neuroimmune Biology (2017)
39. Interleukin-33 Plasma Levels in Patients With Relapsing-Remitting Multiple Sclerosis, Biomolecular Concepts (2017)
40. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
41. Cd24 Gene Allele Variation Is Not Associated With Oligoclonal Igg Bands and Igg Index of Multiple Sclerosis Patients, NeuroImmunoModulation (2012)
42. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
43. Evaluating the Effects of Epigallocatechin-3-Gallate on Hif-1Α Protein and Rorc Gene Expression in Peripheral Blood Mononuclear Cells in Patients With Multiple Sclerosis, Basic and Clinical Neuroscience (2021)
44. Evaluation of Soluble Human Leukocyte Antigen-G (Shla-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2015)
45. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
46. Mannose-Binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders, Iranian Journal of Allergy, Asthma and Immunology (2016)
47. Potential Biomarker and Therapeutic Lncrnas in Multiple Sclerosis Through Targeting Memory B Cells, NeuroMolecular Medicine (2020)
48. Apamin As a Bbb Shuttle and Its Effects on T Cell Population During the Experimental Autoimmune Encephalomyelitis-Induced Model of Multiple Sclerosis, Neurotoxicity Research (2021)
49. Examining the Environmental Risk Factors of Progressive-Onset and Relapsing-Onset Multiple Sclerosis: Recruitment Challenges, Potential Bias, and Statistical Strategies, Journal of Neurology (2024)
50. Cytomegalovirus and Varicella Zoster Virus Seropositivity of Iranian Patients With Multiple Sclerosis: A Population-Based Study, Journal of Neuroimmunology (2017)